Objective:To analyze the implementation effect of centralized procurement policy of Chinese patent medicine alli-ance in Hubei province,and to provide reference and thinking for the implementation and improvement of relevant policies.Meth-ods:To obtain the public medical institutions procurement data of Chinese patent medicines in Hubei Province.The selected varie-ties of Chinese patent medicines with procurement records were taken as the research objects.From May to December 2021 as before the collection and from May to December 2022 as after the collection,the changes of three main indicators,including defined daily doses(DDDs),the amount of purchase and defined daily dose cost(DDDc)were analyzed in this study.Results:The number of purchased Chinese patent medicines and the number of medical institutions purchased increased by 8.89％and 44.35％,respec-tively.Compared with before the collection,the increase of DDDs,purchase amount and DDDc of Chinese patent medicines in pub-lic medical institutions in Hubei Province after collection were 45.26％,-12.94％and-36.58％.The coefficient of variation of DDDs,purchase amount and DDDc growth rate of Chinese patent medicines in each city were 91.41％,850.90％and 436.48％.It was estimated that 45 kinds of Chinese patent medicine with procurement records in Hubei Province before and after the collection have saved a total cost of 83.2126 million after the collection,and the cost saving rate is 24.96％.Conclusion:After the implemen-tation of the Chinese patent medicine collection policy,the usage of drugs has been greatly increased,the drug cost decreased significantly,and the policy cost saving effect was obvious,the accessibility of patients'medication was improved.However,there were obvious differences in the procurement and use of Chinese patent medicines in various cities,and the DDDc of some injections increased.It is necessary to expand the scope of centralized procurement,strengthen the monitoring and management of the procure-ment and clinical use of Chinese patent medicine,improve the price correction mechanism and improve the accessibility of drugs.
关键词
药物政策/集中带量采购/中成药/医疗机构/湖北
Key words
Pharmaceutical Policy/Centralized Drug Volume-based Purchasing/Chinese Patent Medicine/Medical Institu-tion/Hubei
维普
万方数据